ARS Pharmaceuticals (SPRY) Earnings (2020 - 2026)
ARS Pharmaceuticals (SPRY) earnings from Mar 31, 2020 to Mar 31, 2026. The TTM ARS Pharmaceuticals (SPRY) earnings is -$198M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
ARS Pharmaceuticals (SPRY) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1164.18% |
| 3 Years TTM | +67.15% |
| 5 Years TTM | +33.58% |
| All Time TTM | +33.59% |
Annual Earnings change of ARS Pharmaceuticals (SPRY)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$61M | -64.61% |
| 2025 | -$171M | -2241.25% |
| 2024 | $8M | -114.72% |
| 2023 | -$54M | +56.75% |
| 2022 | -$35M | +71.34% |
| 2021 | -$20M | -38.57% |
| 2020 | -$33M | N/A |
Comparison ARS Pharmaceuticals (SPRY) five years earnings CAGR with competitors
ARS Pharmaceuticals (SPRY) five years earnings CAGR is 33.59%.